Log In
Print
BCIQ
Print
Print this Print this
 

Multaq, dronedarone

  Manage Alerts
Collapse Summary General Information
Company Sanofi
DescriptionMultichannel blocker with properties of antiarrhythmics in Vaughan-Williams classes I-IV
Molecular Target Sodium channel ; Potassium channel
Mechanism of ActionK channel blocker; Na channel blocker
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationFibrillation
Indication DetailsControl ventricular rate in atrial fibrillation (AF) patients; Maintain sinus rhythm in atrial fibrillation (AF) patients; Treat atrial fibrillation (AF); Treat atrial fibrillation (AF) and atrial flutter; Treat non-permanent atrial fibrillation (AF); Treat permanent atrial fibrillation (AF)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today